Figure 1From: Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT studyTG and HbA1c levels in patients depending on use of a diabetes drug. The graphs show the changes in HbA1c levels determined for all patients (•), patients taking a diabetes drug (Δ), and patients not taking a diabetes drug (☐).Back to article page